RT Journal Article SR Electronic T1 Abundant Blood Supply and Low P-Glycoprotein Expression on Dynamic 99mTc-MIBI Imaging Predicted Better Chemotherapy Sensitivity for a Breast Cancer Patient: A Case Report JF Journal of Nuclear Medicine Technology JO J. Nucl. Med. Technol. FD Society of Nuclear Medicine SP 89 OP 91 DO 10.2967/jnmt.111.099309 VO 40 IS 2 A1 Si, Hongwei A1 Li, Xianfeng YR 2012 UL http://tech.snmjournals.org/content/40/2/89.abstract AB A patient with a history of breast cancer underwent 3-phase 99mTc-methylene diphosphonate (MDP) imaging followed 3 d later by 3-phase 99mTc-sestamibi (MIBI) imaging. During the vascular and blood-pool phases, a lymph node over the right clavicle was seen on both the 99mTc-MIBI and the 99mTc-MDP scans at as early as 30 s and then became hotter. Four months after receiving chemotherapy, the patient achieved a complete response. The lymph node over the right clavicle vanished on ultrasound examination. The similar distribution of the blood-pool phase between the 99mTc-MDP and 99mTc-MIBI scans indicated that 99mTc-MIBI may similarly provide information on vascularization of the lymph node. In addition to indicating vascularization, our 99mTc-MIBI protocol may simultaneously provide information on P-glycoprotein expression important for predicting chemotherapy sensitivity. With information on the resistance of a tumor to drugs and the environment in which it dwells, chemotherapy sensitivity might be predicted more precisely.